Financial Security Advisor, Inc. Pfizer Inc Transaction History

Financial Security Advisor, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$25.26 - $29.6 $5,355 - $6,275	-212 Reduced 1.8%	11,584 $324 Million
Q1 2024 Apr 18, 2024	SELL	$25.89 - $29.73 $1,889 - $2,170	-73 Reduced 0.62%	11,796 $327 Million
Q4 2023 Jan 24, 2024	SELL	$26.13 - $33.94 $69,740 - $90,585	-2,669 Reduced 18.36%	11,869 $342 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $466,524 - $545,320	14,538 New	14,538 $482 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Financial Security Advisor, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Security Advisor, Inc. with notifications on news.